Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 1/20 | 0.61 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.61 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.61 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.61 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.61 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.61 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.61 |
| ▸ | FURIN | P09958 | 3/20 | 0.52 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.52 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.49 |
| ▸ | CDK2 | P24941 | 2/20 | 0.49 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.49 |
| ▸ | CTSB | P07858 | 1/20 | 0.48 |
| ▸ | CTSK | P43235 | 1/20 | 0.48 |
| ▸ | NPY1R | P25929 | 1/20 | 0.47 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | NPY4R | P50391 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | TLR2 | O60603 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30304268 | 0.91 | GRIN2D (0.57) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL31465333 | 0.88 | VIPR1 (0.52) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL29657723 | 0.83 | GRIN2D (0.57) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL29679875 | 0.83 | GRIN2D (0.51) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL29372015 | 0.82 | GRIN2D (0.59) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL5146835 | 0.82 | GRIN2D (0.59) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL31563685 | 0.82 | GRIN2D (0.59) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL29689190 | 0.82 | GRIN2D (0.50) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL30974509 | 0.82 | GRIN2D (0.56) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL29364756 | 0.82 | NPY1R (0.57) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504949-A | Polypeptide hydrogel, pancreas organoid constructed from polypeptide hydrogel and application of pancreas organoid | 南通大学附属医院 | 2025-02-25 | — | — | CN | claimed |
| CN-117209567-A | Synthesis and application of AIE probe covalently connected with D-type heparin sodium binding peptide | 青岛科技大学 | 2023-12-12 | — | — | CN | claimed |
| EP-3344753-B1 | THREE DIMENSIONAL HYDROGELS FOR CULTURING ORGANOIDS | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2023-04-26 | — | — | EP | claimed |
| US-12584112-B2 | Organoid tissue engineering | Ecolepol Ytechnique Federale de Lausanne (CH) | 2026-03-24 | — | — | US | disclosed |
| EP-4706694-A1 | HYDROGELS FOR CARGO DELIVERY TO TUBULAR EPITHELIAL STRUCTURES | Georgia Tech Research Corporation (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4705434-A1 | MEDIA COMPOSITION FOR INDUCED PLURIPOTENT STEM CELL DERIVED ENDOTHELIAL CELL GROWTH, MONOLAYER FORMATION, AND CELL-CELL CONTACT FORMATION | Lung Biotechnology PBC (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-4683684-A1 | POST-PROCESSING OF BIOLOGICAL SCAFFOLDS | Lung Biotechnology PBC (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-4561834-A1 | TRANSWELL FOR CELL CULTURE, METHOD OF MANUFACTURING WITH SYNTHETIC BIOINK AND IN VITRO TISSUE MODELS | Lung Biotechnology PBC (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2025097016-A1 | PHOTORESPONSIVE HYDROGELS AND USES THEREOF | PRADHAN LINA (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-119836349-A | TRANSWELL for cell culture, method for manufacturing with synthetic bio-ink and in vitro tissue model | 朗格生物技术公共公益股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-119504949-A | Polypeptide hydrogel, pancreas organoid constructed from polypeptide hydrogel and application of pancreas organoid | 南通大学附属医院 | 2025-02-25 | — | — | CN | disclosed |
| CN-117209567-A | Synthesis and application of AIE probe covalently connected with D-type heparin sodium binding peptide | 青岛科技大学 | 2023-12-12 | — | — | CN | disclosed |
| CN-117209567-A | Synthesis and application of AIE probe covalently connected with D-type heparin sodium binding peptide | 青岛科技大学 | 2023-12-12 | — | — | CN | disclosed |
| US-11705122-B2 | Interface-providing apparatus and interface-providing method | KABUSHIKI KAISHA TOSHIBA (JP) | 2023-07-18 | — | — | US | disclosed |
| EP-3344753-B1 | THREE DIMENSIONAL HYDROGELS FOR CULTURING ORGANOIDS | ECOLE POLYTECHNIQUE FED LAUSANNE EPFL (CH) | 2023-04-26 | — | — | EP | disclosed |
| WO-2023028584-A1 | HYDROGELS COMPRISING CELL ADHESIVE PEPTIDES AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2023-03-02 | — | — | WO | disclosed |
| US-20220389374-A1 | USE OF FUNCTIONALIZED AND NON-FUNCTIONALIZED ECMS, ECM FRAGMENTS, PEPTIDES AND BIOACTIVE COMPONENTS TO CREATE CELL ADHESIVE 3D PRINTED OBJECTS | LUNG BIOTECHNOLOGY PBC (US) | 2022-12-08 | — | — | US | disclosed |
| WO-2022236061-A1 | USE OF FUNCTIONALIZED AND NON-FUNCTIONALIZED ECMS, ECM FRAGMENTS, PEPTIDES AND BIOACTIVE COMPONENTS TO CREATE CELL ADHESIVE 3D PRINTED OBJECTS | LUNG BIOTECHNOLOGY PBC (US) | 2022-11-10 | — | — | WO | disclosed |
| US-11478571-B2 | Synthetic hydrogel carriers for cellular structures, generation of organoids, and treatment of tissue injury | GEORGIA TECH RESEARCH CORPORATION (US) | 2022-10-25 | — | — | US | disclosed |
| WO-2022126004-A1 | HYDROGELS ENCAPSULATING ENZYMES THAT DEPHOSPHORYLATE ADENOSINE AND USES IN MEDICAL APPLICATIONS | EMORY UNIVERSITY (US) | 2022-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11478571-B2 | Synthetic hydrogel carriers for cellular structures, generation of organoids, and treatment of tissue injury | KRT18, ILK, CNN2 | GRIN2D 4652/4885GRIN3B 4728/4885GRIN1 4635/4885 |
| US-12584112-B2 | Organoid tissue engineering | KIT, EPCAM, ALPG | GRIN2D 233/4885GRIN3B 2063/4885GRIN1 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.